DSD-T204

Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T204

DSD-T204 · Congenital adrenal hyperplasia (CAH) · 2021 · Automated translation

Genes CYP17A1 · Karyotype 46,XY · Phenotypes HPO:0000062, Ambiguous genitalia (HP:0000062)

46,XX classic 21-hydroxylase deficiency (congenital adrenal hyperplasia) caused by a homozygous CYP21A2 c.515T>A mutation.

Case fields and evidence

Category

Congenital adrenal hyperplasia (CAH)

Age

Neonate (within days after birth)

Sex

Assigned female at birth

Karyotype

46,XY

Genetics

CYP17A1

Phenotypes

Ambiguous genitalia (HP:0000062)

Diagnosis

46,XX classic 21-hydroxylase deficiency (congenital adrenal hyperplasia) caused by a homozygous CYP21A2 c.515T>A mutation.

Follow-up

Not reported in the original text.

General phenotype

Neonatal ambiguous genitalia; no other systemic malformations described.

Imaging

Pelvic and abdominal ultrasound showed a bladder and uterus of normal size, two ovary-like structures in the iliac region, a gonad of about 6×4 mm palpable at the hemiscrotum, no testes in the abdominal cavity, and poorly visualized adrenal regions.

Laboratory findings

ACTH 250 ng/dL (8.0–65.0), total testosterone 22.2 ng/mL, 17-OHP >20 ng/mL (<2), renin 500 U/mL, aldosterone 96.4 ng/dL; cortisol decreased from 12.4 μg/dL on day 1 to 4.8 μg/dL on day 18; LC-MS/MS showed cortisol 3.65 ng/mL and 17-OHP 14.24 ng/mL (0.03–2.65).

Management

Hydrocortisone 10 mg/m²/day (1.5 mg/day) started on postnatal day 12; fludrocortisone 50 μg/day added 1 week later.

Pathology

Not reported in the original text.

Genetic variants

p.Tyr329fs

Evidence level

See source

Clinical history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Limitations

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T204 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T204?version=v1.4.0